Evidence map›Paper›PMID 39810933›Full record

ArticleJournal of diabetes research2025

Shenlian Decoction Ameliorates LPS-Related Inflammation in db/db Mice: Coupling Network Pharmacology With Experimental Verification.

Yi-Fan Liu, Yuan-Yuan Liu, Yao Xiao, Wei-Jun Huang, Rui-Xi Sun, Jie Hu, Xiao-Zhe Fu, Chu-Xiao Tian, Qiang Fu, Jin-Xi Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yi-Fan LiuSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0003-4002-9433
Yuan-Yuan LiuInstitute of Chinese Medical Literature and Culture, Shandong University of Traditional Chinese Medicine, Jinan, China.ORCID https://orcid.org/0009-0006-7261-4716
Yao XiaoNephropathy Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-3267-2325
Wei-Jun HuangKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-2704-4674
Rui-Xi SunInstitute of Basic Theory, China Academy of Chinese Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0002-8553-9333
Jie HuSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0004-6629-8337
Xiao-Zhe FuSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0008-1638-1596
Chu-Xiao TianSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0007-9846-4012
Qiang FuSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-4409-1237
Jin-Xi ZhaoSection II of Endocrinology & Nephropathy Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-0593-2152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Inflammatory AgentsDiabetes Mellitus, Type 2Drugs, Chinese HerbalInflammationAnimalsLipopolysaccharidesMaleMiceMyeloid Differentiation Factor 88Network PharmacologyNF-kappa BProtein Interaction MapsSignal TransductionToll-Like Receptor 4Anti-Inflammatory AgentsDrugs, Chinese HerbalLipopolysaccharidesMyeloid Differentiation Factor 88NF-kappa BToll-Like Receptor 4inflammationLPSnetwork pharmacologyShenlian decoctionType 2 diabetes

Identifiers

PMID39810933
PMCPMC11729506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.